Position in ANNX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,004,658
+$469,395 QoQ
Shares Held
903,368
-0.0% QoQ
Ownership
0.453%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2020
23 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ANNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $1,374,765,738 across 53 Biotechnology names. ANNX ranks #21 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
1,860,669 | $425,590,816 | |
| 2 | TECH |
BIO-TECHNE Corp
|
3,733,248 | $195,099,537 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
496,004 | $164,112,841 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
327,498 | $146,240,953 | |
| 5 | LGND |
Ligand Pharmaceuticals Inc
|
411,543 | $82,164,559 | |
| 6 | BNTX |
BioNTech SE
|
670,514 | $59,595,283 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
666,116 | $50,018,650 | |
| 8 | INCY |
Incyte Corp
|
410,729 | $38,657,809 |
All Filings in ANNX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,004,658 | 903,368 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,535,263 | 903,439 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $2,989,869 | 980,285 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,370,031 | 987,513 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $1,969,404 | 1,020,417 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $5,214,983 | 1,016,566 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,872,445 | 1,160,886 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $5,217,524 | 1,064,801 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $5,548,963 | 773,914 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,531,974 | 777,968 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,834,189 | 777,199 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $2,731,006 | 775,854 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $3,018,515 | 784,030 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $4,056,873 | 784,695 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $4,833,575 | 782,132 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $2,751,127 | 729,742 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $2,007,379 | 735,304 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $8,212,833 | 714,781 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $13,401,712 | 720,135 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $16,425,839 | 729,713 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $20,373,840 | 731,819 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $21,853,142 | 873,078 | Shares | Sole | 2021-05-12 | |
| 2020-09-30 | $25,908,319 | 857,040 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||